UBS Group AG

Holdings History for Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX)

Symbol: BDTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$626,048	257,633	-370,783	-59%	$2.43	Q4 2025
30 Sep 2025	0%	+0%	$2,381,696	628,416	+314,716	+100%	$3.79	Q3 2025
30 Jun 2025	0%	+0%	$777,975	313,700	+185,906	+145%	$2.48	Q2 2025
31 Mar 2025	0%	+0%	$198,081	127,794	+77,901	+100%	$1.55	Q1 2025
31 Dec 2024	0%	+0%	$106,771	49,893	+11,436	+30%	$2.14	Q4 2024
30 Sep 2024	0%	+0%	$167,288	38,457	+11,923	+45%	$4.35	Q3 2024
30 Jun 2024	0%	+0%	$123,648	26,534	+22,263	+521%	$4.66	Q2 2024
31 Mar 2024	0%	0%	$21,654	4,271	+284	+7.1%	$5.07	Q1 2024
31 Dec 2023	0%	+0%	$11,203	3,987	+3,741	+1521%	$2.81	Q4 2023
30 Sep 2023	0%	-0%	$706	246	-8,273	-97%	$2.87	Q3 2023
30 Jun 2023	0%	+0%	$43,021	8,519	+8,519	NEW	$5.05	Q2 2023
31 Mar 2023		-0%	$0	0	-3,433	-100%	$2.39	Q1 2023
31 Dec 2022	0%	-0%	$6,179	3,433	-1,942	-36%	$1.80	Q4 2022
30 Sep 2022	0%	-0%	$9,000	5,375	-12,224	-69%	$1.67	Q3 2022
30 Jun 2022	0%	-0%	$44,000	17,599	-3,221	-15%	$2.50	Q2 2022
31 Mar 2022	0%	-0%	$58,000	20,820	-8,734	-30%	$2.79	Q1 2022
31 Dec 2021	0%	+0%	$157,000	29,554	+12,733	+76%	$5.31	Q4 2021
30 Sep 2021	0%	+0%	$143,000	16,821	+5,454	+48%	$8.50	Q3 2021
30 Jun 2021	0%	-0%	$139,000	11,367	-31,822	-74%	$12.23	Q2 2021
31 Mar 2021	0%	+0%	$1,048,000	43,189	+43,189	NEW	$24.27	Q1 2021
31 Dec 2020		-0%	$0	0	-197	-100%	$2.39	Q4 2020
30 Sep 2020	0%	-0%	$6,000	197	-4,457	-96%	$30.46	Q3 2020
30 Jun 2020	0%	-0%	$196,000	4,654	-2,577	-36%	$42.11	Q2 2020
31 Mar 2020	0%	+0%	$180,000	7,231	+7,231	NEW	$24.89	Q1 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.